Minerva Neurosciences, Inc. - Special Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Minerva Neurosciences December 18, 2019 Conference Call. (Operator Instructions)
I would now like to hand the conference to your speaker today, William Boni, Vice President of Investor Relations. Please go ahead, sir.
Good evening, everyone. A press release announcing top line results from the Phase IIb trial of MIN-117 became available at 4:05 p.m. Eastern Time today and can be found on the Investors section of our website.
Joining me on the call today from Minerva are Dr. Rémy Luthringer, Executive Chairman and Chief Executive Officer; Mr. Geoff Race, Executive Vice President, Chief Financial Officer and Chief Business Officer; and Mr. Rick Russell, President. Following our prepared remarks, we will open the call for Q&A.
Before we begin, I would like to remind you that today's discussion will include statements about the company's future expectations, plans and prospects
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |